Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 11 - 04    symbols : Nvs    save search

Worldwide Menopause Industry to 2026 - Prevalence of Herbal Treatment for Menopause Presents Opportunities
Published: 2021-11-04 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K twitter stocktwits trandingview |
Health Technology
| | O: 3.11% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M twitter stocktwits trandingview |
Health Technology
| | O: -3.06% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.42% H: 0.38% C: 0.37%
GSK | News | $40.86 -0.92% -0.15% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 0.51% C: 0.39%

treatment
Novartis iptacopan meets primary endpoints in Phase II study in rare kidney disease C3 glomerulopathy (C3G)
Published: 2021-11-04 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.89%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.28% C: 0.18%

disease kidney rare
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.89%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.28% C: 0.18%
INCY | $51.72 0.14% 0.14% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.41% H: 0.0% C: 0.0%

ema car-t platform
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.